ARTICLE | Clinical News
Davanat: Preliminary Phase II data
April 10, 2006 7:00 AM UTC
Preliminary data from the Phase II trial with Davanat as third- and fourth-line treatment of colorectal cancer showed that a patient had an objective partial tumor response as defined by at least 50% ...